Validity of the Dmba-Induced Mammary Cancer Model for the Study of Human Breast Cancer

Huggins C. , Grand L.C. , Brillantes F.P. Mammary cancer induced by a single feeding of polynuclear hydrocarbons, and its suppression. Nature 1961; 1: 204–7.

Huggins C. , Morii S. , Grand L.C. Mammary cancer induced by a single dose of polynuclear hydrocarbons: routes of administration. Ann Surg 1961; 1: 315–8.

Heuson J.C. , Legros N. , Heuson-Stiennon J.A. , Leclerq G. , Pasteels J.L. Hormone dependency of rat mammary tumours. In: Heuson J.C. , Matteiem W.H. , Rozencweig M. , eds. Breast cancer: trends in research and treatment. New York: Raven Press, 1976; 81–93.

Escrich E. Efecto de un derivado androgénico sobre la inducción y el crecimiento de tumores mamarios experimentales. Bellaterra: Universidad Autónoma de Barcelona, ed., 1985.

Mobbs B.G. The uptake of tritiated oestradiol by di-methylbenzanthracene-induced mammary tumours of the rat. J Endocrin 1966; 1: 409–14.

Smith R.D. , Hilf R. , Senior A.E. Prolactin binding to mammary gland, 7, 12-dimethylbenz(a)anthracene-induced mammary tumors, and liver in the rats. Cancer Res 1976; 1: 3726–31.

Koenders A.J.M. , Guerts-Moespot A. , Zolingen S.J. , Benraad ThJ . Progesterone and estradiol receptors in DMBA-induced mammary tumors before and after ovariectomy and after subsequent estradiol administration. In: McGuire W.L. , Raynaud J.P. , Baulieu E.E. , eds. Progesterone receptors in normal and neoplastic tissues. New York: Raven Press, 1977; 71–83.

Isaacs J.T. Determination of the number of events required for mammary carcinogenesis in the Sprague-Dawley female rat. Cancer Res 1985; 1: 4827–32.

Young S. , Hallowes R.C. Tumours of the mammary gland. In: Turosov V.S. , ed. Pathology of tumours in laboratory animals. Vol I. Lyon: IARC, 1973; 31–74.

Huggins Ch , Briziarelli G. , Sutton H. Rapid induction of mammary carcinoma in the rat and the influence of hormones on the tumors. J Experimental Med 1959; 1: 25–42.

Peckham J.C. Experimental oncology. In: Baker J.R. , Lindsey J.R. , Weisbroth S.H. , eds. The laboratory rat. Vol II. New York: Academic Press, 1980; 119–47.

Jabara A.G. , Harcourt A.G. Effects of progesterone, ovariectomy and adrenalectomy on mammary tumours induced by 7, 12-dimethylbenz(a) anthracene in Sprague-Dawley rats. Pathology 1971; 1: 209–14.

Teller M.N. , Stock CCh , Bowie M. Effects of 17α-thioestradiol, 2 estradiol analogs, and 2 androgens on 7, 12-dimethylbenz(a) anthracene-induced rat mammary tumors. Cancer Res 1966; 1: 2329–33.

Meites J. Relation of prolactin and estrogen to mammary tumorogenesis in the rat. J of Nat Cancer Inst 1972; 1: 1217–24.

Kledzik G.S. , Bradley C.J. , Meites J. Reduction of carcinogen - induced mammary cancer incidence in rats by early treatment with hormones or drugs. Cancer Res 1974; 1: 2953–56.

Kelly P.A. , Asselin J. , Labrie F. , Raynaud J.P. Regulation of hormone receptor levels and growth of DMBA-induced mammary tumors by RU16117 and other steroids in the rat. In: Mc Guire W.L. , Raynaud J.P. , Baulieu E.E. , ed. progesterone receptors in normal and neoplastic tissues. New York: Raven Press, 1977; 85–101.

Huggins Ch , Moon R.C. , Morii S. Extinction of experimental mammary cancer I. Estradiol-17B and progesterone. Proc Natl Acad Sci USA 1962; 1: 379–86.

Hilf R. Reaciones dosis-tiempo en el efecto de los estrógenos sobre el cancer mamario. In: Revisiones Cancer Endocrino-Dependiente, Febrero 1979; 11–6.

Yoshida H. , Yoshida A. , Yamada M. , Yamanaka K. , Kitamura Y. , Matsumoto K. Regression with secretory changes of ovary-independent rat mammary carcinoma by pharmacological doses of estrogen. Jpn J Cancer Res (Gann) 1985; 1: 771–8.

Raynaud J.P. , Bouton M.M. , Azadian-Boulanger G. Oestrogènes et anti-oestrogiènes steroidiens de synthèse. In: Masson, Les oestrogènes, 1977; 289–98.

Rochefort H. , Capony F. Mécanisme d'action des anti-estroeènes de synthèse. In: Masson, Les oestrogènes, 1977; 299–308.

Anderson J.N. , Peck E.J. , Clark J.H. Estrogen-induced uterine responses and growth: relationship to receptorestrogen binding by uterine nuclei. Endocrinology 1975; 1: 160–7.

Rudali G. , Apiou F. , Muel B. Mammary cancer produced in mice with estriol. Europ J Cancer 1975; 1: 39–41.

Noble R.L. , Hochachka B.C. , King D. Spontaneous and estrogen-produced tumors in Nb rats and their behaviour after transplantation. Cancer Res 1975; 1: 766–80.

Lemon H.M. Abnormal estrogen metabolism and tissue estrogen receptor proteins in breast cancer. Cancer 1970; 1: 4323–35.

Horwitz K.B. , McGuire W.L. Estrogen and progesterone: their relationship in hormone-dependent breast cancer. In: McGuire W.L. , Raynaud J.P. , Baulieu E.E. , eds. Progesterone receptors in normal and neoplastic tissues. New York: Raven Press, 1977; 103–24.

Milgrom E. , Thi L. , Atger M. , Baulieu E.E. Mechanisms regulating the concentration and the conformation of progesterone receptor(s) in the uterus. J Biol Chem 1973; 1: 6366–74.

Rochefort H. Régulation physiologique et pharmacologique des récepteurs des oestrogènes. In: Inserm , eds. Hormone and breast cancer. Paris, 1976; 83–96.

Hsueh A.J.W. , Peck E.J. , Clark J.H. Control of uterine estrogen receptor levels by progesterone. Endocrinology 1976; 1: 438–44.

Tseng L. , Gurpide E. Effects of progestins on estradiol receptor levels in human endometrium. J Clin Endocrinol Metab 1975; 1: 402–4.

Sasaki G.H. , Leung B.S. On the mechanism of hormone action in 7, 12-dimethylbenz(a) anthracene-induced mammary tumor. I. Prolactin and progesterone effects on estrogen receptor “in vitro”. Cancer 1975; 1: 645–51.

Jabara A.G. Effects of progesterone on 9, 10-dimethyl-1, 2-benzanthracene-induced mammary tumours in Sprague-Dawley rats. Br J Cancer 1967; 1: 418–29.

Saez S. , Mayer M. Oestrogènes et cancer du sein. In: Masson Les oestrogènes, 1977; 227–43.

Sterental A. , Dominguez J.M. , Weissman C. , Pearson O.H. Pituitary role in the estrogen dependency of experimental mammary cancer. Cancer Res 1963; 1: 481–4.

Aguilar E. , Fernandez C. , Vaticon M.D. , Tejero A. Action of oestrogens on prolactin secretion. Phar-matherapeutica 1980; 2, suppl 1: 113–6.

Vignon F. , Rochefort H. Régulation des “récepteurs” des oestrogènes an les tumeurs mammaires: effet de la prolactine “in vivo”. C R Acad Sc Paris 1974; 1: 103–6.

Vignon F. , Rochefort H. Regulation of estrogen receptors in ovarian-dependent rat mamary tumors. I. Effects of castration and prolactin. Endocrinology 1976; 1: 722–9.

Welsch C.W. , Calaf G. , Brenna M.J. DNA synthesis of human, mouse, and rat mammary carcinomas in vitro. Cancer 1976; 1: 1272–81.

Leung B.S. , Sasaki G.H. On the mechanism of prolactin and estrogen action in 7, 12-dimethylbenz(a) anthracene-induced mammary carcinoma in the rat. II. In vivo tumor responses and estrogen receptor. Endocrinology 1975; 1: 564–72.

Heuson J.C. , Legros N. Effect of insulin and of alloan diabetes on growth of the rat mammary carcinoma in vivo. Europ J Cancer 1970; 1: 349–51.

Cohen N.D. , Hilf R. Influence of insuline on growth and metabolism of 7, 12-dimethylbenz(a) anhracene-induced mammary tumors. Cancer Res 1974; 1: 3245–52.

Hilf R. , Hissin P.J. , Shafie S.M. Regulatory interrelationships for insulin and estrogen action in mammary tumors. Cancer Res 1978; 1: 4076–85.

Pearson O.H. , Llerena O. , Llerena R. , Molina A. , Butler T. Prolactin dependent rat mammary cancer. A model for man?. Trans Assoc Am Physicians 1969; 1: 225–38.

Nagasawa H. , Yanai R. Effects of prolactin and growth hormone on growth of carcinogen-induced mammary tumors of adreno-ovariectomized rats. Int J Cancer 1970; 1: 488–95.

Saez S. Corticotrophin secretion in relation to beast cancer. In: Stoll B.A. , ed. Mammary cancer and neuroendocrine therapy. London: Butterworths, 1974; 101–22.

Saez S. , Mayer M. Facteurs hormonaux de prevision d'hormono-dependance du cancer du sein. Bulletin du Cancer 1977; 1: 557–66.

Saez S. La fonction surrenalienne dans le cancer. Relation avec l'evolution. In: Inserm , eds. Hormones and Breast Cancer. 1975; 205–14.

Saez S. , Bertrand J. Recepterus cellulaires et mecanisme d'action des hormones steroides. Lyon Pharmaceutique 1977; 1: 11–34.

Nicholson R.I. , Davies P. , Griffiths K. Tamoxifen binding in mammary tumours in relation to response. In: Mayer M. , Saez S. , Stoil B.A. , eds. Reviews on Endocrine-Related Cancer. Suppl April 1978; 306–21.

Capony F. , Rochefort H. High-affinity binding of the anti-estrogen (³H)Tamoxifen to the 8 S estradiol receptor. Molecular and Cellular Endocrinology 1978; 1: 181–9.

Heuson J.C. , Waelbroeck C. , Legros N. , Gallez G. , Robyn C. , L'Hermite M. Inhibition of DMBA-in-duced mammary carcinogenesis in the rat by 2-Br-α-ergocryptine (CB 154), and inhibitor of prolactin secretion, and by nafoxidine (U-11, 100 A), an estrogen antagonist. Gynec Invest 1971/72; 1: 130–7.

Desombre E.R. , Arbogast L.Y. Effect of the antiestro-gen CI628 on the growth of rat mammary tumors. Cancer Res 1974; 1: 1971–6.

King R.J.B. , Cowan D.M. , Inman D.R. The uptake of (6, 7-³H) oestradiol by dimethylbenzanthracene-induced rat mammary tumours. J Endocrin 1965; 1: 83–90.

Jensen E.V. , Desombre E.R. , Junblut P.W. Estrogen receptors in hormone responsive tissues and tumors. In: Voissler R.W. , Dao T.L. , Wood S. , eds. Endogenous factors influencing breast tumor balance. Chicago: University Press, 1967; 15–30.

McGuire W.L. , Julian J.A. Comparison of macromolecular binding of estradiol in hormone-dependent and hormone-independent rat mammary carcinoma. Cancer Res 1971; 1: 1440–5.

Leclerq G. , Heuson J.C. Specific estrogen receptor of the DMBA-induced mammary carcinoma of the rat and its estrogen-requiring molecular transformation. Europ J Cancer 1973; 1: 675–80.

Desombre E.R. , Kledzik G. , Marshall S. , Meites J. Estrogen and prolactin receptor concentrations in rat mammary tumors and response to endocrine ablation. Cancer Res 1976; 1: 354–8.

Asselin J. , Labrie F. , Kelly P.A. , Philibert D. , Raynaud J.P. Specific progesterone receptors in dimethylben-zanthracene (DMBA)- induced mammary tumors. Steroids 1976; 1: 395–404.

Turkington R.W. Prolactin receptors in mammary carcinoma cells. Cancer Res 1974; 1: 758–63.

Harris C.C. , Trump B.F. , Stoner G.D. Methods in cell Biology. New York: Academic Press, 1980, vols 21A and 21B.

Griswold D.P. , Green ChH . Observations on the hormone sensitivity of dimethylbenz(a)anthracene-in-duced mammary tumors in the Sprague-Dawley rat. Cancer Res 1970; 1: 819–26.

McGuire W.L. , Delagarza M. Similarity of the estrogen receptor in human and rat mammary carcinoma. J Clin Endocrinol Metab 1973; 1: 548–52.

European Breast Cancer Group. Clinical trial of 2-Br-α-ergocryptine (CB154) in advanced breast cancer. Europ J Cancer 1972; 1: 155–6.

Barret A. , Desouza I. , Fairney A. , Morgan L. , Raggat P.R. , Salih H. , Hobbs J.R. Prolactin-dependent breast cancer. In: Inserm eds. Hormones and breast cancer, 1975; 123–7.

Minton J.P. The response of breast cancer patients with bone pain to 1-dopa. Cancer 1974; 1: 358–63.

Saski G.H. , Leung B.S. , Fletcher W.S. Levo dopa test and estrogen receptor assay in prognosticating responses of patients with advanced cancer of the breast to endocrine therapy. Ann Surg 1976; 1: 392–6.

Rozencweig M. , Heuson J.C. , Bila S. , L'Hermite M. , Robyn C. Effects of 2-Br-α-ergocryptine, 1-dopa and cyclic imides on serum prolactin in postmenopausal women. Europ J Cancer 1973; 1: 657–64.

Bulbrook R.D. , Wang D.Y. Prolactina: etiologia del cancer mamario y hormonodependencia en el hombre. In: Stoll B.A. , ed. Revisiones Cancer Endocrino-Dependiente. 1981; 13–19.

Selwood R.A. Hormonas sexuales y neoplasias mamarias. In: Revisiones Cancer Endocrino-Dependiente. Suppl Oct 1979; 5–11.

Hill P. , Wynder E.L. , Kumar H. , Hlrnen P. , Rova G. , Kuno K. Prolactin levels in populations at risk for breast cancer. Cancer Res 1976; 1: 4102.